These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 21565234)

  • 41. Salmonella-based tumor-targeted cancer therapy: tumor amplified protein expression therapy (TAPET) for diagnostic imaging.
    Tjuvajev J; Blasberg R; Luo X; Zheng LM; King I; Bermudes D
    J Control Release; 2001 Jul; 74(1-3):313-5. PubMed ID: 11489512
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Oncolytic HSV1 targets different growth phases of breast cancer leptomeningeal metastases.
    Kuruppu D; Bhere D; Farrar CT; Shah K; Brownell AL; Mahmood U; Tanabe KK
    Cancer Gene Ther; 2023 Jun; 30(6):833-844. PubMed ID: 36721067
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Cancer imaging: Gene transcription-based imaging and therapeutic systems.
    Bhang HE; Pomper MG
    Int J Biochem Cell Biol; 2012 May; 44(5):684-9. PubMed ID: 22349219
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Positron emission tomography and gene therapy: basic concepts and experimental approaches for in vivo gene expression imaging.
    Peñuelas I; Boán J; Martí-Climent JM; Sangro B; Mazzolini G; Prieto J; Richter JA
    Mol Imaging Biol; 2004; 6(4):225-38. PubMed ID: 15262238
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Tracing transgene expression in cancer gene therapy: a requirement for rational progress in the field.
    Sangro B; Qian C; Ruiz J; Prieto J
    Mol Imaging Biol; 2002 Jan; 4(1):27-33. PubMed ID: 14538046
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Clostridial spores as live 'Trojan horse' vectors for cancer gene therapy: comparison with viral delivery systems.
    Wei MQ; Ren R; Good D; Anné J
    Genet Vaccines Ther; 2008 Feb; 6():8. PubMed ID: 18279524
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [HSV1-derived vectors: a powerful and flexible system for genes transfers].
    Thomas J; Cuchet D; Potel C; Epstein AL
    Virologie (Montrouge); 2007 Oct; 11(5):339-350. PubMed ID: 36131442
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Molecular-genetic imaging of cancer.
    Minn I; Menezes ME; Sarkar S; Yarlagadda K; Das SK; Emdad L; Sarkar D; Fisher PB; Pomper MG
    Adv Cancer Res; 2014; 124():131-69. PubMed ID: 25287688
    [TBL] [Abstract][Full Text] [Related]  

  • 49. A window into metastasis.
    Brucker D; Herms J
    Sci Transl Med; 2012 Oct; 4(158):158fs39. PubMed ID: 23115352
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Virus-based nanomaterials as positron emission tomography and magnetic resonance contrast agents: from technology development to translational medicine.
    Shukla S; Steinmetz NF
    Wiley Interdiscip Rev Nanomed Nanobiotechnol; 2015; 7(5):708-21. PubMed ID: 25683790
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 18F-glutathione conjugate as a PET tracer for imaging tumors that overexpress L-PGDS enzyme.
    Huang HL; Huang YC; Lee WY; Yeh CN; Lin KJ; Yu CS
    PLoS One; 2014; 9(8):e104118. PubMed ID: 25111383
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Synthesis and biological evaluation of a new acyclic pyrimidine derivative as a probe for imaging herpes simplex virus type 1 thymidine kinase gene expression.
    Meščić A; Betzel T; Müller A; Slavik R; Cermak S; Raić-Malić S; Ametamey SM
    Molecules; 2013 Jul; 18(7):8535-49. PubMed ID: 23877048
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Generation of destabilized herpes simplex virus type 1 thymidine kinase as transcription reporter for PET reporter systems in molecular genetic imaging.
    Hsieh CH; Chen FD; Wang HE; Hwang JJ; Chang CW; Lee YJ; Gelovani JG; Liu RS
    J Nucl Med; 2008 Jan; 49(1):142-50. PubMed ID: 18077523
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Herpes simplex virus thymidine kinase as a marker/reporter gene for PET imaging of gene therapy.
    Blasberg RG; Tjuvajev JG
    Q J Nucl Med; 1999 Jun; 43(2):163-9. PubMed ID: 10429512
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Combination of pet imaging with viral vectors for identification of cancer metastases.
    Brader P; Wong RJ; Horowitz G; Gil Z
    Adv Drug Deliv Rev; 2012 Jun; 64(8):749-55. PubMed ID: 21565234
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Molecular-genetic PET imaging using an HSV1-tk mutant reporter gene with enhanced specificity to acycloguanosine nucleoside analogs.
    Najjar AM; Nishii R; Maxwell DS; Volgin A; Mukhopadhyay U; Bornmann WG; Tong W; Alauddin M; Gelovani JG
    J Nucl Med; 2009 Mar; 50(3):409-16. PubMed ID: 19223410
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Positron emission tomography-based imaging of transgene expression mediated by replication-conditional, oncolytic herpes simplex virus type 1 mutant vectors in vivo.
    Jacobs A; Tjuvajev JG; Dubrovin M; Akhurst T; Balatoni J; Beattie B; Joshi R; Finn R; Larson SM; Herrlinger U; Pechan PA; Chiocca EA; Breakefield XO; Blasberg RG
    Cancer Res; 2001 Apr; 61(7):2983-95. PubMed ID: 11306477
    [TBL] [Abstract][Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.